Chromosol is commercialising optical amplifiers for semiconductors that transmit data via light pulses rather than as electrical signals.

The Tufts spinout has not identified any of its investors in the round, which will go towards the launch of a feed additive to prevent avian livestock infections.

The speciality chemicals developer will celebrate the launch of its first enzyme-manufactured chemical product, a grapefruit flavour and scent, during 2018.

ADCendo will develop a single oncology therapy combining antibodies with cytotoxic drugs used during chemotherapy.

MIT machine learning interface spinout Pienso has been backed by Eniac Ventures, SoftTech VC, Indicator Ventures and E14 Fund.

Northwestern University spinout Exicure, formerly known as AuraSense Therapeutics, has added $11.2m to its latest funding round with contributions from Purple Arch Ventures.

Topas has closed its series A round at nearly $21m, following a $4.6m extension that will be used to advance potential autoimmune disease therapies towards clinical trials.

The Stanford-StartX fund-backed cloud computing optimisation platform has brought in $30m in a round that took its total funding to $140m.

The bacterial infections drug developer, based on research at Harvard Medical School, has gone public.